or Try an Advanced Search...

    Technical Analysis for MNMD - Mind Medicine (MindMed) Inc.

    Grade Last Price % Change Price Change
    B 8.97 -6.66% -0.64
    MNMD closed up 0.63 percent on Wednesday, May 8, 2024, on 36 percent of normal volume.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical MNMD trend table...
    Date Alert Name Type % Chg
    MACD Bullish Signal Line Cross Bullish -6.66%
    Bollinger Band Squeeze Range Contraction -6.66%
    BB Squeeze Started Range Contraction -6.66%
    Gapped Down Weakness -6.66%
    Crossed Above 20 DMA Bullish -6.07%
    180 Bullish Setup Bullish Swing Setup -6.07%
    Bearish Engulfing Bearish -2.71%
    Fell Below 20 DMA Bearish -2.71%
    Multiple of Ten Bearish Other -2.71%
    Gapped Up Strength -2.71%
    Older End-of-Day Signals for MNMD ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 4 hours ago
    2x Volume Pace about 5 hours ago
    1.5x Volume Pace about 5 hours ago
    Lower Bollinger Band Support about 5 hours ago
    Down 2 ATRs about 5 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    MNMD Chart by TradingView
    Basic chart:

    Profile

    Mind Medicine (MindMed) Inc., a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. The company is headquartered in New York, New York.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Drugs Drug Development Psychoactive Drugs Entheogens Psychedelic Drug N Dimethyltryptamine

    Is MNMD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US
    May 9 Mind Medicine (MindMed) Inc. (MNMD) Q1 2024 Earnings Call Transcript
    May 8 Mind Medicine GAAP EPS of -$1.14 misses by $0.60
    May 8 MindMed Reports First Quarter 2024 Financial Results and Business Updates
    May 7 Mind Medicine Q1 2024 Earnings Preview
    May 6 MindMed releases promising phase 2 data on LSD-related anxiety therapy
    May 4 MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York
    May 2 MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update
    Apr 29 Psychedelic drug developers could benefit from NIH funding for chronic pain
    Apr 26 MindMed: Breakthrough Status From The FDA For LSD Therapy
    See more MNMD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.22
    52 Week Low 2.41
    Average Volume 2,710,958
    200-Day Moving Average 5.02
    50-Day Moving Average 9.10
    20-Day Moving Average 9.28
    10-Day Moving Average 9.29
    Average True Range 0.74
    RSI (14) 53.49
    ADX 21.81
    +DI 26.59
    -DI 17.42
    Chandelier Exit (Long, 3 ATRs) 8.77
    Chandelier Exit (Short, 3 ATRs) 10.40
    Upper Bollinger Bands 10.33
    Lower Bollinger Band 8.23
    Percent B (%b) 0.66
    BandWidth 22.65
    MACD Line 0.10
    MACD Signal Line 0.09
    MACD Histogram 0.0096
    Fundamentals Value
    Market Cap 385.31 Million
    Num Shares 40.1 Million
    EPS -1.87
    Price-to-Earnings (P/E) Ratio -5.14
    Price-to-Sales 0.00
    Price-to-Book 1.84
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 10.51
    Resistance 3 (R3) 10.51 10.22 10.36
    Resistance 2 (R2) 10.22 9.99 10.22 10.31
    Resistance 1 (R1) 9.91 9.85 10.07 9.91 10.26
    Pivot Point 9.62 9.62 9.69 9.62 9.62
    Support 1 (S1) 9.31 9.39 9.47 9.31 8.96
    Support 2 (S2) 9.02 9.25 9.02 8.91
    Support 3 (S3) 8.71 9.02 8.86
    Support 4 (S4) 8.71